BIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biotest AG

Watchlist Manager

Watchlist

Price: 101.26 EUR 0.98% Market Closed

Market Cap: €4B

B	Biotest AG F:BIO	DE
	Pieris Pharmaceuticals Inc F:PI6	US
B	Bruker Corp XBER:BKD	US
	Phoenix New Media Ltd NYSE:FENG	CN
	Boyd Group Services Inc F:3YT	CA
U	United Tractors Tbk PT XMUN:UTY	ID
	Reitmans Canada Ltd OTC:RTMNF	CA
P	PennyMac Mortgage Investment Trust F:8PM	US
S	Sprouts Farmers Market Inc XMUN:1FA	US
E	Equinox Gold Corp AMEX:EQX	CA
	Arvind Ltd NSE:ARVIND	IN
C	Canadian Imperial Bank of Commerce F:CAI	CA
	Imugene Ltd ASX:IMU	AU
	Privia Health Group Inc NASDAQ:PRVA	US

Profitability Summary

Biotest AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

23%

Sustainable 3Y Average Gross Margin

34%

Gross Margin is Increasing

22% > 23%

Low Operating Margin

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

-3% > 2%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Net Margin is Increasing

-8% > -4%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-23% > 2%

Negative ROE

-5%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.